Target Name: ZNF302
NCBI ID: G55900
Review Report on ZNF302 Target / Biomarker Content of Review Report on ZNF302 Target / Biomarker
ZNF302
Other Name(s): HSD16 | Zinc finger protein 302, transcript variant 1 | zinc finger protein 327 | ZNF327 | ZNF302 variant 1 | MSTP154 | MST154 | Zinc finger protein 135-like | Zinc finger protein 302 (isoform c) | ZN302_HUMAN | Zinc finger protein 140-like | Zinc finger protein 327 | ZNF140L | zinc finger protein 302 | Zinc finger protein 302 | ZNF135L

ZNF302: Key Regulator of Stem Cell Proliferation and Tissue Development

ZNF302 (HSD16) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a key regulator of cell growth, differentiation, and survival, and is involved in the development and maintenance of tissues. ZNF302 has also been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of ZNF302 is its role in the regulation of stem cell proliferation. Stem cells are a type of cell that have the ability to develop into any type of cell in the body, and they play a crucial role in the development and maintenance of tissues. ZNF302 is involved in the regulation of stem cell proliferation by controlling the activity of several key genes.

In addition to its role in stem cell biology, ZNF302 is also involved in the regulation of cellular processes that are important for tissue development and maintenance. For example, ZNF302 is involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues. ZNF302 also plays a role in the regulation of cell migration, which is the process by which cells move from one location to another in the body.

In addition to its involvement in stem cell biology and cellular processes, ZNF302 is also implicated in a number of diseases. For example, ZNF302 has been implicated in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells, and they can have a significant impact on an individual's quality of life.

Another potential application of ZNF302 is as a drug target or biomarker. The regulation of stem cell proliferation and cellular processes by ZNF302 is an attractive target for the development of new treatments for a variety of conditions. For example, ZNF302 has been shown to be involved in the regulation of cellular processes that are important for the development and maintenance of cancer cells. Therefore, ZNF302 may be a useful target for the development of new cancer therapies.

In addition to its potential as a drug target, ZNF302 is also a potential biomarker for a variety of conditions. For example, ZNF302 has been shown to be involved in the regulation of cellular processes that are important for the development and maintenance of many different types of tissues, including brain, heart, and kidney tissues. Therefore, ZNF302 may be a useful biomarker for a variety of conditions, including cancer, neurodegenerative diseases, and autoimmune disorders.

Overall, ZNF302 is a protein that is involved in a number of important cellular processes that are involved in the development and maintenance of tissues. Its regulation of stem cell proliferation and cellular processes by controlling the activity of several key genes makes it an attractive target for the development of new treatments for a variety of conditions. Furthermore, ZNF302 is also a potential biomarker for a variety of conditions, which could be used to diagnose and monitor these conditions.

Protein Name: Zinc Finger Protein 302

Functions: May be involved in transcriptional regulation

The "ZNF302 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF302 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330 | ZNF331 | ZNF333 | ZNF334 | ZNF335 | ZNF337 | ZNF33A | ZNF33B | ZNF33BP1 | ZNF34 | ZNF341 | ZNF341-AS1 | ZNF343 | ZNF345 | ZNF346 | ZNF347 | ZNF35 | ZNF350 | ZNF350-AS1 | ZNF354A | ZNF354B | ZNF354C | ZNF355P | ZNF358 | ZNF362 | ZNF365 | ZNF366 | ZNF367 | ZNF37A | ZNF37BP | ZNF382 | ZNF383 | ZNF384 | ZNF385A | ZNF385B | ZNF385C | ZNF385D | ZNF385D-AS1 | ZNF385D-AS2 | ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398 | ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414 | ZNF415 | ZNF416 | ZNF417 | ZNF418 | ZNF419 | ZNF420 | ZNF423 | ZNF425 | ZNF426 | ZNF428 | ZNF429 | ZNF43 | ZNF430 | ZNF431 | ZNF432 | ZNF433 | ZNF433-AS1 | ZNF436 | ZNF436-AS1 | ZNF438 | ZNF439 | ZNF44 | ZNF440 | ZNF441 | ZNF442 | ZNF443 | ZNF444 | ZNF445 | ZNF446